Fig. 2From: FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trialStudy schedule. AFAST, Adult Female Acne Scoring Tool; EQ-5D, Euroqol-5 dimensions; CADI, Cardiff Acne Disability Index; D, day; M, monthBack to article page